Latest News
Evaxion presents new preclinical data on cytomegalovirus vaccine EVX-V1
13 July 2026 - Evaxion A/S (NASDAQ: EVAX), a Denmark-based clinical-stage TechBio company developing novel vaccines with its AI-Immunology platform, on Sunday presented new data further supporting the multi-component concept of its cytomegalovirus (C...
HDT Bio Launches Canadian clinical programme for brain cancer treatment
13 July 2026 - US-based clinical-stage biotechnology company HDT Bio Corp announced on Sunday the establishment of HDT Bio Canada Inc, its Canadian subsidiary, formed to advance its cancer immunotherapy programs through Canadian clinical development,...
Insilico Medicine and CMS to collaborate further on CNS diseases
13 July 2026 - Clinical-stage biotechnology company Insilico Medicine (HKEX:3696) announced on Sunday that it has agreed an additional AI-empowered drug discovery collaboration with China Medical System Holdings Limited (CMS) (HKEX:867) (SGX:8A8) tar...
Antengene receives USD60m upfront payment from UCB
13 July 2026 - Chinese biotech company Antengene Corporation Limited (SEHK:6996) announced on Monday that the company has received a USD60m upfront payment from UCB (Euronext Brussels:UCB) under the worldwide exclusive licence agreement for ATG-201, ...
BioArctic's partner Eisai presents new clinical data on Leqembi subcutaneous autoinjector at AAIC 2026
13 July 2026 - Swedish research-based biopharma company BioArctic AB (STO:BIOA-B) said on Monday that its Japanese partner Eisai Co Ltd (TYO:4523) presented new data at the 2026 Alzheimer's Association International Conference (AAIC) in London, ...